{"id":"W2557055491","doi":"10.1016/j.ijcard.2016.11.046","title":"Open-label therapy with alirocumab in patients with heterozygous familial hypercholesterolemia: Results from three years of treatment","year":2016,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Université de Montréal; Montreal Clinical Research Institute","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Alirocumab; Medicine; Ezetimibe; Statin; Internal medicine; Adverse effect; Clinical endpoint; Familial hypercholesterolemia; Apolipoprotein B; Gastroenterology; Clinical trial; Cholesterol","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004478928,0.0004889432,0.001744333,0.0002530461,0.0005405603,0.0009288852,0.0004011287,0.001006642,0.002720385],"category_scores_gemma":[0.002969818,0.0001729003,0.003118704,0.0004698076,0.0004614444,0.0009241751,0.0005990483,0.002020799,0.000475567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008517149,"about_ca_system_score_gemma":0.001106568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009715423,"about_ca_topic_score_gemma":0.001608488,"domain_scores_codex":[0.998163,0.0007910721,0.0002473586,0.0002116091,0.0002896547,0.0002972828],"domain_scores_gemma":[0.9948975,0.001079155,0.001577691,0.0005881176,0.0005576556,0.001299801],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5444989,0.02744025,0.03493724,0.002249521,0.005815574,0.0003013184,0.0009241506,0.0009097574,0.01323784,0.0002328367,0.005099212,0.3643535],"study_design_scores_gemma":[0.2316368,0.3968138,0.3411894,0.0005971774,0.006713999,0.0007947265,0.0003798295,0.00127821,0.004349618,0.0004285768,0.01567475,0.0001430982],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9800124,0.01490229,0.000676398,0.0006510622,0.0001463129,0.0006241369,0.0009802175,0.00005316559,0.001954202],"genre_scores_gemma":[0.98959,0.003909559,0.0008598915,0.001097493,0.0003062726,0.0008314305,0.002405588,0.00001652824,0.000983322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004478928,"threshold_uncertainty_score":0.02368712,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0295306507424814,"score_gpt":0.2921693733172047,"score_spread":0.2626387225747233,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}